Medscape InDiscussion: Multiple Sclerosis

Listen to Medscape InDiscussion: Multiple Sclerosis, a podcast series where thought leaders and clinical experts share their diverse insights and practical ideas for optimizing patient care. Relevant disclosures can be found with the episode show notes on Medscape (https://www.medscape.com/viewarticle/977030). The topics and discussions are planned, produced, and reviewed independently of advertisers. This podcast is intended only for US healthcare professionals.

Medscape InDiscussion: Multiple Sclerosis is a science podcast hosted by Medscape, with 12 episodes on record and a Required Pod Score of 80. PitchCentric scores this show on Booking Probability, Listen Score, and live audience signals refreshed every 24 hours.

Medscape hosts Medscape InDiscussion: Multiple Sclerosis, a science show with 12 episodes published.

Our AI reads these to draft pitches. Use them as grounding for a pitch that cites a real guest and a specific topic.

• 

  Episode #6

  Can Fluid Biomarkers Predict MS Progression?

  Nov 20, 202528 minS2

  <p>Could NfL and GFAP redefine how clinicians track progression in MS? Dr Mark Freedman joins Dr Anne Cross to explain the evolving science behind these powerful biomarkers.</p> <p>Relevant disclosures can be found with the episode show notes on Medscape https://www.medscape.com/viewarticle/1002608. The topics and discussions are planned, produced, and reviewed independently of advertisers. This podcast is intended only for US healthcare professionals.</p> <p>Resources</p> <p>Multiple Sclerosis https://emedicine.medscape.com/article/1146199-overview</p> <p>Fluid Biomarkers in Multiple Sclerosis: From Current to Future Applications https://pubmed.ncbi.nlm.nih.gov/39444698/</p> <...

  ListenShow Notes
• 

  Episode #5

  Can Imaging Biomarker Breakthroughs Help Us See MS More Clearly?

  Oct 21, 202527 minS2

  <p>How can imaging biomarkers enhance our understanding of MS? Dr Anne Cross and Dr Matthew Brier examine MRI advancements that provide new insights into diagnosis, progression, and treatment.</p> <p>Relevant disclosures can be found with the episode show notes on Medscape https://www.medscape.com/viewarticle/1002607. The topics and discussions are planned, produced, and reviewed independently of advertisers. This podcast is intended only for US healthcare professionals.</p> <p>Resources</p> <p>Multiple Sclerosis https://emedicine.medscape.com/article/1146199-overview</p> <p>Emerging MRI Biomarkers for the Diagnosis of Multiple Sclerosis https://pubmed.ncbi.nlm.nih.gov/39511991/</p> <...

  ListenShow Notes
• 

  Episode #4

  Should Platform Therapies Remain First-Line in MS?

  Sep 18, 202526 minS2

  <p>Drs Anne Cross and Scott Newsome discuss new horizons in MS treatment strategies, including the TREAT-MS trial and shared decision-making for optimal patient care.</p> <p>Relevant disclosures can be found with the episode show notes on Medscape https://www.medscape.com/viewarticle/1002606. The topics and discussions are planned, produced, and reviewed independently of advertisers. This podcast is intended only for US healthcare professionals. </p> <p>Resources</p> <p>Multiple Sclerosis https://emedicine.medscape.com/article/1146199-overview</p> <p>Interferon Beta and Glatiramer Acetate Therapy https://pubmed.ncbi.nlm.nih.gov/23264098/</p> <p>Traditional Versus Early Aggressive Therapy for Mu...

  ListenShow Notes
• 

  Episode #3

  Progress in Progressive MS: BTK Inhibitors and the HERCULES Study

  Aug 20, 202527 minS2

  <p>Can BTK inhibitors finally move the needle in progressive MS? Dr Robert Fox joins Dr Anne Cross to unpack the results of the HERCULES trial and explore what's next.</p> <p>Relevant disclosures can be found with the episode show notes on Medscape https://www.medscape.com/viewarticle/1002605. The topics and discussions are planned, produced, and reviewed independently of advertisers. This podcast is intended only for US healthcare professionals. </p> <p>Resources</p> <p>Tolebrutinib in Nonrelapsing Secondary Progressive Multiple Sclerosis https://pubmed.ncbi.nlm.nih.gov/40202696/</p> <p>Bruton Tyrosine Kinase Inhibitors in Multiple Sclerosis: Evidence and Expectations ht...

  ListenShow Notes
• 

  Episode #2

  The Exercise Prescription for MS Just Got Stronger

  Jul 16, 202526 minS2

  <p>Join Drs Anne Cross and Rob Motl as they discuss how new data and clinical insights are reshaping how exercise helps people with MS.</p> <p>Relevant disclosures can be found with the episode show notes on Medscape https://www.medscape.com/viewarticle/1002604. The topics and discussions are planned, produced, and reviewed independently of advertisers. This podcast is intended only for US healthcare professionals.</p> <p>Resources</p> <p>Intrathecal Baclofen for Multiple Sclerosis–Related Spasticity: A Twenty-Year Experience https://pubmed.ncbi.nlm.nih.gov/30366276/</p> <p>Prevalence of Depression and Anxiety in Multiple Sclerosis: A Systematic Review and Me...

  ListenShow Notes

Recent guests on Medscape InDiscussion: Multiple Sclerosis. Study who booked and why before you pitch.

Based on semantic analysis of episode topics and host coverage, this show is a strong guest fit for executives in:

Industry fit is computed by PitchCentric using vector embeddings of the show's episode catalog.